Indoco gets EIR from US FDA for its solid dosages facility (Plant I) in Verna, Goa

Indoco Remedies Ltd, a fully integrated, research-oriented pharma company, announced the receipt of an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the US Food and Drug Administration (FDA) for their facility for solid dosages (Plant I) located in Verna, Goa. The recent inspection held from January 16, 2023, to January 20, 2023, was a surveillance inspection. The receipt of the EIR with VAI status also signifies the imminent closeout of the Warning Letter issued by the US FDA in July 2019 for the manufacturing site, situated at L-14, Verna Industrial Road, Goa (Plant I). Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site. Commenting on this positive development, Aditi Kare Panandikar, managing director

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!